High On-treatment Platelet Reactivity Identified by Multiple Platelet Function Assay

NACompletedINTERVENTIONAL
Enrollment

477

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

August 31, 2015

Study Completion Date

October 31, 2015

Conditions
Acute Coronary Syndrome
Interventions
DRUG

Clopidogrel

Antiplatelet agent

DRUG

Ticagrelor

New P2Y12 receptor inhibitor antiplatelet agent

Trial Locations (1)

430022

Wuhan Asia Heart Hospital, Wuhan

All Listed Sponsors
lead

Wuhan Asia Heart Hospital

OTHER

NCT02699008 - High On-treatment Platelet Reactivity Identified by Multiple Platelet Function Assay | Biotech Hunter | Biotech Hunter